Dana-Farber, EDI partner to provide new app to improve communication during serious illness

NewsGuard 100/100 Score

Dana-Farber Cancer Institute and the EDI Institute are partnering to provide a new mobile imaging technique for cancer patients, family members, and staff to express their feelings around the illness. Expressive Digital Imagery (EDI) is used on a smartphone or tablet to provide a creative outlet for people to express complex feelings and emotions that words alone cannot.

Using a new and specialized app, program participants begin with ordinary photographs and easily transform them into expressive images that communicate meaningful aspects of their lives. At Dana-Farber, people can use their own mobile devices or borrow one. As part of the program, participants can print the images in books at no charge through special grant funds.

EDI pilots in multiple clinical settings have shown that therapeutic self-expression through digital imagery can play an important role in helping patients, family members, and clinical providers deal with illness and treatment.

"We are excited to offer EDI to our patients, family, and staff as it complements our ongoing efforts to help people face the challenges of cancer diagnosis and treatment," said Patricia Stahl, M.Ed, manager of Volunteer Programs and Services. "This innovative program uses therapeutic self-expression which has shown to be a very effective creative outlet and tool to help communication during serious illness," she added.

"We are thrilled to be bringing the power of EDI to Dana-Farber and to those impacted by cancer, an illness that causes complex feelings that frequently are inaccessible through words alone," added Steven Koppel, Founder of the EDI Institute. "Through this partnership, we look forward to integrating EDI into the fabric of special care that Dana-Farber provides."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Combined chemohormonal therapy for locally advanced prostate cancer offers extended control of PSA levels